Contineum Therapeutics, Inc. (CTNM) Misses Q4 EPS by 11c

Contineum Therapeutics, Inc. (NASDAQ: CTNM) reported Q4 EPS of ($0.56), $0.11 worse than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Contineum Therapeutics, Inc. (CTNM) click here.

You May Also Be Interested In

• Methode Electronics (MEI) Tops Q1 EPS by 2c; offers guidance
• After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
• Netskope, Inc. (NTSK) Tops Q2 EPS by 4c, Offers Guidance